Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to Bristol Myers Squibb was $1.5 billion, or $0.69 per share, compared to a net profit of $1.9 billion, or $0.82 per share, last year. Adjusted net earnings were $4.5 billion, or $2.00 per share.
Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to Bristol Myers Squibb was $1.5 billion, or $0.69 per share, compared to a net profit of $1.9 billion, or $0.82 per share, last year. Adjusted net earnings were $4.5 billion, or $2.00 per share.
Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings.
Revenues increased 10% year-over-year to $11.6 billion.
Net earnings attributable to Bristol Myers Squibb was $1.5 billion, or $0.69 per share, compared to a net profit of $1.9 billion, or $0.82 per share, last year.
Adjusted net earnings were $4.5 billion, or $2.00 per share.
